DTI Tightens Monitoring on Vape Shops in Manila

Jun.08.2023
DTI Tightens Monitoring on Vape Shops in Manila
DTI tightens monitoring of e-cigarette shops in Manila to ensure compliance with vape regulation laws.

On June 8th, according to the Philippine News Agency, Fred Pascual, the Secretary of the Department of Trade and Industry (DTI) of the Philippines, ordered the strengthening of monitoring of e-cigarette shops in the National Capital Region (NCR) to ensure compliance with sales restrictions outlined in the Vaporized Nicotine and Non-Nicotine Products Regulation Act. DTI has monitored a total of 29,167 shops, including 583 physical stores and 28,584 online stores.


Minister Pascal of the Department of Trade and Industry stated:


The Department of Trade and Industry, through its Fair Trade Enforcement Bureau (FTEB), will continue to enhance its monitoring of these businesses. The goal is to ensure a balance between the interests of the companies/manufacturers while protecting the youth from the harmful effects of these substances.


As of June 1st, DTI has monitored a total of 29,167 stores, including 583 physical stores and 28,584 online shops.


Out of the 583 physical stores monitored, 229 were found to be compliant while 214 were not. On the other hand, only 175 out of 28,584 online stores that underwent physical inspections were compliant, while 2,809 were found to be non-compliant. An additional 26,986 online stores are currently undergoing physical inspections.


Based on the monitoring results stated above, the Fair Trade Enforcement Bureau (FTEB) has issued violation notices/reasons for non-compliance to 72 businesses. The Department of Trade and Industry (DTI) also seized 13,784 products from non-compliant shops, with a retail value of approximately 4.25 million Philippine pesos (equivalent to around 540,000 yuan).


The vast majority of companies that have received notice letters for reasons of non-compliance are engaged in the following violations:


The fourth regulation pertains to the packaging requirements for products. The fifth regulation pertains to the sale of nicotine and non-nicotine products, as well as their equipment or new tobacco products. The sixth regulation pertains to restrictions on the dissemination, advertising, and sponsorship of products. The eighth regulation prohibits the use of vape products in public places. As of June 1st, the DTI's adjudication department has received 74 formal charges, with 73 against physical stores and 1 against an online store. The DTI is monitoring major social media and e-commerce platforms to ensure that minors cannot purchase these substances online.


The Philippines has recently intensified its crackdown on illegal e-cigarettes, targeting both brick-and-mortar stores and online retailers. This comes after the passage of the Vaporous Nicotine and Non-Nicotine Products Regulation Act in 2022, which aims to regulate the import, manufacturing, sale, packaging, distribution, use and dissemination of vaporized nicotine and non-nicotine products (including e-cigarettes) and new tobacco products.


The Department of Trade and Industry (DTI) has mandated stricter supervision of vaporizer shops in the metropolitan area of Manila.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
According to Reuters, major tobacco companies may emerge as key beneficiaries after the U.S. FDA loosened regulations on vaping and nicotine pouch products, a shift that has sparked debate over public health risks.
Industry Insight
May.26
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
LOST MARY Launches VIZ With Transparent Wraparound Pod and LED Display
LOST MARY Launches VIZ With Transparent Wraparound Pod and LED Display
LOST MARY announced VIZ on May 6, 2026, describing it as the brand’s first product with a transparent 360-degree wraparound pod.
May.07 by 2FIRSTS.ai
Putin Signs Russia’s Tobacco and Nicotine Product Licensing Law, Banning Unlicensed Sales From 2027
Putin Signs Russia’s Tobacco and Nicotine Product Licensing Law, Banning Unlicensed Sales From 2027
Russian President Vladimir Putin has signed a law introducing mandatory licensing for wholesale and retail trade in tobacco and nicotine-containing products, with the system taking effect on October 1, 2026, and unlicensed operations banned from March 1, 2027, while vape and e-liquid retail may also face uncertainty from temporary regional sales-ban powers.
Jul.01
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
British American Tobacco (BAT) subsidiary Vuse Alto has recently adjusted its price tiers in U.S. convenience store channels, leveraging low-cost device kits and pod promotions to reinforce its positioning in the mid-priced closed-system e-cigarette market.
Jun.17
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Researchers at the Chinese Academy of Sciences reconstructed nicotine biosynthesis in non-tobacco plants and yeast systems, highlighting how advances in synthetic biology could gradually reshape future nicotine production technologies and challenge regulatory frameworks built around tobacco-derived definitions.
Special Report
May.07